Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 6, Issue 2, 2024

Analysis on the Rule of Medication in the Treatment of Pulmonary Nodules by Professor Ma Zhanping

Download as PDF

DOI: 10.23977/medcm.2024.060217 | Downloads: 2 | Views: 57

Author(s)

Hongmei Liu 1, Zhanping Ma 1,2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Shaanxi Provincial Hospital of Chinese Medicine, Xi'an, Shaanxi, 710003, China

Corresponding Author

Zhanping Ma

ABSTRACT

To explore the rule of medication of Professor Ma Zhanping in the treatment of pulmonary nodules by using data mining technology. Medical records of patients with pulmonary nodules who first visited Professor Ma Zhanping's clinic from January 2023 to December 2023 were collected. Excel2021 was used to analyze the frequency, sex, taste and normalization of traditional Chinese medicine, and SPSSModeler18.0 was used to analyze drug association rules for network display. 108 prescriptions were included, including 137 kinds of traditional Chinese medicine. The total frequency of use was 1564 times, and there were 16 kinds of drugs with frequency ≥30 times. The top 10 were licorice, codonopsis codonopsis, Bupleurum, orange peel, Coix seed, Angelica sinensis, Tangerine kernel, Astragalus, Thunbertillaria and cohote. The four Qi are mainly warm, the five taste are mainly sweet and bitter, and the channel is mainly lung, followed by stomach channel. Dr. Ma Zhanping believed that the main pathogenesis of pulmonary nodules was deficiency of healthy qi and aggregation of phlegm and blood stasis. The core prescription for treating this disease was tonifying deficiency drug, strengthening spleen drug, activating blood stasis drug and clearing heat drug.

KEYWORDS

Pulmonary Nodules, Data Mining, Drug Use Rule, Ma Zhanping

CITE THIS PAPER

Hongmei Liu, Zhanping Ma, Analysis on the Rule of Medication in the Treatment of Pulmonary Nodules by Professor Ma Zhanping. MEDS Chinese Medicine (2024) Vol. 6: 136-143. DOI: http://dx.doi.org/10.23977/medcm.2024.060217.

REFERENCES

[1] Interstitial Lung Diseases Group, Respiratory Medicine Branch, Chinese Medical Association, interstitial Lung Diseases Working Committee, Respiratory Medicine Branch, Chinese Medical Doctor Association. Expert consensus on diagnosis and treatment of pulmonary sarcoidosis in China[J]. Chinese Journal of Tuberculosis and Respiratory, 2019, 42(9): 685-693.
[2] Xia Y, Liu Q, Zhao T, et al. Progress of clinical research on lung nodules in Chinese and western medicine[J]. Yunnan Journal of Traditional Chinese Medicine, 2024, 45(01): 97-100.
[3] Yang Jie, Li Qiushi, Zhao Sen. Diagnostic value of CT and magnetic resonance imaging in patients with pulmonary nodules[J]. Heilongjiang Medicine, 2024, 48(06): 686-688.
[4] Liu Junqi, Qian Weijun, Li Li, et al. Differential diagnostic value of benign and malignant lung nodule imaging features and quantitative parameters[J]. China Medical Engineering, 2024, 32(03): 25-30.
[5] Wu B, Ma J, Shi H. Progress in early diagnosis of benign and malignant lung nodules. International Journal of Surgery, 2020, 47(07): 484-485.
[6] Sun Lian, Ma Hongping, Wu Wenying. Research progress in diagnosis and surgical treatment of pulmonary nodules [J]. Marker Immunoassay and Clinical, 2023, 30(08): 1431-1434+1440.
[7] Ni Yuanyuan, Wang Zhiyuan, Zhao Zhengyang. Discussion on Chinese medicine treatment of pulmonary nodules based on disease and body identification [J]. Liaoning Journal of Chinese Medicine, 2024, 51(03): 60-62.
[8] Li Xue, Liu Shuo, Wang Xueqian, et al. Advantages of Chinese medicine in preventing and treating pulmonary nodules and thinking about it[J]. China Journal of Basic Chinese Medicine, 2023, 29(11): 1814-1817.
[9] Zhang Xiaoju, Bai Li, Jin Guangming, et al. Chinese expert consensus on the diagnosis and treatment of pulmonary nodules (2018 edition)[J]. Chinese Journal of Tuberculosis and Respiratory, 2018, 41(10): 763-771.
[10] National Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China [S]. Beijing: China Medical Science and Technology Press, 2020.
[11] Editorial Committee of Chinese Materia Medica. State Administration of Traditional Chinese Medicine. Chinese Materia Medica 6[M]. Shanghai: Shanghai Science and Technology Press, 1999.
[12] Yang Lihui, Li Jinghua, Zhou Tian, et al. Current status and thoughts on the research of lung nodules in Chinese medicine[J]. Chinese Journal of Traditional Chinese Medicine, 2024, 39(03): 1431-1436.
[13] Qiao Yu, Xi Zhaoqing. Analysis of Chinese medicine understanding of pulmonary nodules[J]. Chinese Folk Therapy, 2022, 30(22): 7-10.
[14] Zhang Huiting, Jiang Keyuan, Wang Yiming, et al. Discussion on the name and pathogenesis of lung nodules in Chinese medicine[J]. Bright Chinese Medicine, 2022, 37(03): 389-392.
[15] Xia Y, Liu Q, Zhao T, et al. Progress of clinical research on lung nodules in Chinese and western medicine[J]. Yunnan Journal of Traditional Chinese Medicine, 2024, 45(01): 97-100.
[16] Zhang Zhaoyang, Sun Zengtao, Liu Nanfei, et al. Research on the theory and clinical application of lung-spleen related theories[J]. Shaanxi Traditional Chinese Medicine, 2020, 41(11): 1623-1626+1631.
[17] Lanxin Zhang, Jiawei Wang, Tong Zhou, et al. Treatment of lung cancer from spleen and stomach based on the theory of "when spleen and stomach are weak, lung qi will be cut off first"[J/OL]. Global Chinese Medicine, 2024, 1-5
[18] Liu Wenxin, Yang Shuang, Sun Zengtao. Exploration of the theory of "deficiency of the spleen and stomach of the lung" and its application in pulmonary diseases[J]. Hunan Journal of Traditional Chinese Medicine, 2022, 38(05): 99-101.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4808
Visits: 203133

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.